Skip to content


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
  • Email this article
  • View or print a PDF of this page
  • Share further
  • Add this article to your Pinterest board
  • Add this article to your Google page
  • Share this article on Reddit
  • Share this article on StumbleUpon
  • Bookmark this page

ARIAD Pharmaceuticals: Transforming technology to accelerate science and improve productivity for the benefit of patients

With increasing demands placed on IT, growing biopharmaceutical company ARIAD was facing intensifying challenges with their existing IT infrastructure, systems and services - constraining their ability to operate and importantly, launch a promising new lung cancer drug.

A new Chief Information Officer engaged us to help plan and manage a program to modernize and improve all aspects of IT. Around the same time, ARIAD management decided to move their offices to a purpose-built, state-of-the-art premises, which would also have the benefit of bringing all their people into a single building.

We started with an application architecture and infrastructure blueprint, which allowed us to understand the current environment, identify application gaps and duplications, and to see which problems were a priority. We also decided on some fundamental changes including moving much of what had been stored and managed in-house to the cloud.

We recommended the latest technology including Microsoft Surface Hubs which allow people to collaborate in real time. We also helped ARIAD to identify, negotiate with, and transition to new suppliers for their IT services. 

For ARIAD, we managed the introduction of the new and improved services, infrastructure and technology without any break in services while maintaining their legacy environment. It was important to take a coordinated approach to make sure people would accept changes, adopt different technologies and stick with them. Now that the move is complete and ARIAD are in their new offices, we’re decommissioning their old technology.  As a result of the changes, ARIAD are continuing their scientific discovery while preparing for the potential launch of a new cancer drug.

“PA brought the right people to address our challenges.  From strategic thinking and planning to operational implementation, they were pragmatic and worked shoulder to shoulder with us; fundamentally changing how IT was used within the company.  They made our team successful and we aligned around a patient centric approach to IT solutions.”

Nick Ventresca
SVP and Chief Information Officer
ARIAD Pharmaceuticals


By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.